A profitable company with shrinking sales.
Facts from SEC filings, not a recommendation.
From MNSB's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $67.5M, down 52% from the 12 months before.
Move the sliders to your own view of MNSB. Starting points are the company's recent numbers.
What today's price needs: with a 26% margin and a 10x P/E, sales could shrink about 2.9% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: debt under half of equity, share count not growing. A checklist is a starting point for research, not a verdict.
Revenue and EPS as the company states them. Margins, cash flow and share count fill in with the 10-Q.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions cut 4.1% from their holdings. 58 bought, 24 sold. 2 quarters of net selling in a row.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
971 shares at $24.74 · $24K
849 shares at $24.74 · $21K
973 shares at $24.69 · $24K
973 shares at $24.69 · $24K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page